Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001897612-25-000545·T. Rowe Price Investment Management, Inc.
Schedule 13G ownership disclosure
Vaxcyte Inc
COMMON STOCK · CUSIP: 92243G108
Event date: 2025-09-30
- Filing-level shares
- 8,315,476
- Percent of class
- 6.4%
- T. Rowe Price Investment Management, Inc.
Shares: 8,315,476 · Class: 6.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-25-000545
- Form type
- SCHEDULE 13G
- Filer
- T. Rowe Price Investment Management, Inc.
- CIK
- CIK 1897612
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership